Vertex Pharmaceuticals to build research centre at Harwell

Summarised from 2 outlets · Updated 2 Nov, 06:02 · Archive

Vertex Pharmaceuticals plans to build a 155,000 sq ft research facility at Harwell Campus in Didcot, Oxfordshire.

Vertex Pharmaceuticals has chosen Harwell Campus in Didcot as the site for a major new research facility. The 155,000 sq ft centre will focus on developing advanced medicines and follows Moderna's recent arrival at the Oxfordshire campus.

Since launching in 2016, the Health Tech Cluster at Harwell has grown substantially to include more than 75 life sciences organisations and 1,400 people. Professor Michele Dougherty, executive chair of the Science and Technology Facilities Council, said the new facility 'will develop transformative medicines' and 'complements our outstanding national labs, strengthens Oxfordshire's position as a home for world-class life sciences'.

Jim Stretton, managing director of Harwell Campus, said the investment 'reflects the strength of Harwell's health cluster and Oxfordshire's thriving research and innovation ecosystem'. Harwell Campus is managed through a joint venture between the Science and Technology Facilities Council, the UK Atomic Energy Authority, and private investor Brookfield.

How it is being reported

• Global biopharma company invests in major Oxfordshire research centreVertex Pharmaceuticals plans to build a 155,000 sq ft centre at Harwell Campus.Oxford Mail · 2 Nov, 05:00
• Global biopharma company invests in major Oxfordshire research centreVertex Pharmaceuticals plans to build a 155,000 sq ft centre at Harwell Campus.Oxfordshire Guardian · 2 Nov, 05:00

In this story: Vertex Pharmaceuticals · Harwell Campus · Didcot · Oxfordshire · Science and Technology Facilities Council · Moderna

This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem · Corrections log